Edwards Lifesciences Corporation Income Tax Effects Allocated Directly to Equity
Edwards Lifesciences Corporation (EW) reported Income Tax Effects Allocated Directly to Equity of $5.10 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-28.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquity · last filed 2011-02-28
- Edwards Lifesciences Corporation income tax effects allocated directly to equity for fiscal 2010 was $5.10M.
| Period end | Income Tax Effects Allocated Directly to Equity 12 month |
|---|---|
| 2010-12-31 | $5.10M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |